A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis
Authors
Andrea De Giacomo (ORCID: https://orcid.org/0000-0002-3454-1679)
Agenzia Italiana del Farmaco, Ministero della Salute
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis
Andrea De Giacomo, Lucia Margari, Stefania Micella, Mariagrazia Felisi et al.
Citations
1 citations
Journal
Neurological Sciences
Topics
Multiple Sclerosis Research Studies
Field-Weighted Citation Impact (FWCI)
1.47
article
A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis
Andrea De Giacomo, Lucia Margari, Stefania Micella, Mariagrazia Felisi, Massimiliano Valeriani, Donato Bonifazi, Mariaclara Achille, Antonia Peschechera, Valentina Torri Clerici, Giorgio Reggiardo, Laura Papetti, Roberto Palumbi, Lucia Marzulli, Alessandra Gabellone, Roberta Lanzillo, Mara Pascali, Marta Simone, Rosa Padula, Giulia Maggi
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Neurological SciencesVol. 46(10)
Institutions
University of Rome Tor Vergata (IT), Consorzio per Valutazioni Biologiche e Farmacologiche (IT), Bambino Gesù Children's Hospital (IT), European Centre for Training and Research in Earthquake Engineering (IT), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT), Aalborg University (DK)
Funders
Agenzia Italiana del Farmaco, Ministero della Salute